Efficacy of adjunctive use of mitomycin C in dacryocystorhinostomy: a meta-analysis

PDF(667 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2012, Vol. 23 ›› Issue (4) : 305-308.

ZHANG Shede1，ZHANG Tianfeng2，LUO Rong1，and ZHONG Xiuhua1.

Author information +

History +

Abstract

Objective To evaluate the efficacy and safety of adjunctive use of mitomycin C in dacryocystorhinostomy to treat lacrimal passage obstruction．Methods We searched the Cochrane Library，EMbase，PubMed，CBM，CNKI and VIP to collect randomized controlled trials (RCT) of use of mitomycin C in dacryocystorhinostomy．The quality of the included trials was assessed and meta-analyses were conducted by using RevMan 5.1 software．We conducted subgroup analyses based on the outcome measures and intervention． Results A total of 18 randomized controlled trials involving 1139 eyes were included．There were significant differences in symptom-freedom and patency of the lacrimal drainage system and ostium size of external dacryocystorhinostomy with and without mitomycin C. Although there was no significant difference between the two groups in symptom-freedom and patency of the lacrimal drainage system, the difference was statistically significant in the ostium size of endonasal dacryocystorhinostomy. There were no severe postoperative complications. Conclusions The adjunctive use of mitomycin C improves the efficacy of dacryocystorhinostomy.

Key words

mitomycin C / dacryocystorhinostomy / randomized controlled trial / meta-analysis

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Efficacy of adjunctive use of mitomycin C in dacryocystorhinostomy: a meta-analysis[J]. Medical Journal of the Chinese People Armed Police Forces. 2012, 23(4): 305-308

References

［1］Janssen A G, Mansour K, Bos J J,et al. Diameter of the bony lacrimal canal: normal values and values related to nasolacrimal duct obstruction: assessment with CT ［J］. Am J Neuroradiol, 2001, 22(5): 845-850.

［2］Duffy M T. Advances in lacrimal surgery ［J］. Curr Opin Ophthalmol, 2000, 11(5): 352-356.

［3］Dolmetsch A M. Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults ［J］. Ophthalmology, 2010, 117(5): 1037-1040.

［4］Prasannaraj T, Kumar B Y, Narasimhan I,et al. Significance of adjunctive mitomycin C in endoscopic dacryocystorhinostomy ［J］. Am J Otolaryngol, 2012, 33(1): 47-50.

［5］Ahmad S S, Untoo R A. Results of intraoperative mitomycin C application in dacryocystorhinostomy ［J］. J k Science, 2002, 4(1): 27-31.

［6］Coppens G, Maudgal P. Corneal complications of intraoperative mitomycin C in glaucoma surgery ［J］. Bull Soc Belge Ophtalmol, 2010, 314:19-23.

［7］Jadad A R, Moore R A, Carroll D,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary［J］. Control Clin Trials, 1996, 17(1):1-12.

［8］Schulz K F, Chalmers I, Hayes R J,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials ［J］. JAMA, 1995, 273(5): 408-412.

［9］Ari S, Gun R, Surmeli S,et al. Use of adjunctive mitomycin C in external dacryocystorhinostomy surgery compared with surgery alone in patients with nasolacrimal duct obstruction: a prospective, double-masked, randomized, controlled trial ［J］. Curr Ther Res Clin E, 2009, 70(4): 267-273.

［10］Eshraghy B, Raygan F, Tabatabaie S Z,et al. Effect of mitomycin C on success rate in dacryocystorhinostomy with
silicone tube intubation and improper flaps ［J］. Eur J Ophthalmol, 2011, 7(1): 1-4.

［11］Farahani F, Ramezani A. Effect of intraoperative mitomycin C application on recurrence of endoscopic dacryocystorhinostomy ［J］. Saudi Med J, 2008, 29(9): 1354-1356.

［12］Kao S C, Liao C L, Tseng J H,et al. Dacryocystorhinostomy with intraoperative mitomycin C ［J］. Ophthalmology, 1997, 104(1): 86-91.

［13］Liao S L, Kao S C, Tseng J H,et al. Results of intraoperative mitomycin C application in dacryocystorhinostomy ［J］.
Br J Ophthalmol, 2000, 84(8): 903-906.

［14］Roozitalab M H, Amirahmadi M, Namazi M R. Results of the application of intraoperative mitomycin C in dacryocystorhinostomy［J］. Eur J Ophthalmol, 2004, 14(6): 461-463.

［15］Tirakunwichcha S, Aeumjaturapat S, Sinprajakphon S. Efficacy of mitomycin C in endonasal endoscopic dacryocystorhinostomy ［J］. Laryngoscope, 2011, 121(2): 433-436.

［16］Yildirim C, Yaylali V, Esme A,et al. Long-term Results of adjunctive use of mitomycin C in external dacryocystorhinostomy ［J］. Int Ophthalmol, 2007, 27(1): 31-35.〖JP〗

［17］李敏，冉红军，王兴正. 丝裂雷素C在泪囊鼻腔吻合术中的应用［J］. 眼外伤职业眼病杂志, 2002, 24(4): 432.

［18］李永忠，汪建平. 丝裂雷素C对泪囊鼻腔吻合术的影响［J］. 中华现代中西医杂志, 2004, 2(9): 775-776.

［19］罗燕珊. 丝裂雷素C在外路泪囊鼻腔吻合术中的应用［J］. 宁夏医学杂志, 2004, 26(6): 323-325.

［20］牛洪明，高丽华，林雪媛，等. 丝裂雷素C在泪囊鼻腔吻合术中的应用［J］. 国际眼科杂志, 2004, 4(3): 554-555.

［21］邱四可，秦军,王皓月, 等. MMC在泪囊鼻腔吻合术中的应用［J］. 眼科新进展, 2001, 21(2): 107-108.〖JP〗

［22］鄢秀菊，吴成富. 丝裂霉素应用于鼻腔泪囊吻合术疗效探讨［J］. 重庆医学, 2002, 31(10): 954-955.

［23］游逸安，方春庭. MMC在泪囊鼻腔吻合术中应用的远期疗效观察［J］. 中国实用眼科杂志, 2003, 21(2): 139-142.

［24］张弘. MMC在改良泪囊鼻腔吻合术中的疗效观察［J］. 实用临床医学, 2007, 8(5): 97-98.

［25］Tabatabaie S Z, Heirati A, Rajabi M T,et al. Silicone intubation with intraoperative mitomycin C for nasolacrimal duct obstruction in adults: a prospective, randomized, double-masked study ［J］. Ophthal Plast Reconstr Surg, 2007, 23(6): 455-458.

［26］Leong S C, Macewen C J, White P S. A systematic review of outcomes after dacryocystorhinostomy in adults［J］. Am J Rhinol Allergy, 2010, 24(1): 81-90.